Board Member
Foghorn Therapeutics Inc. (FHTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Foghorn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get FHTX alertsAdrian Gottschalk is recorded as CEO and Board Member at Foghorn Therapeutics Inc. (FHTX). The newest filing on record that lists Adrian Gottschalk as CEO and Board Member at Foghorn Therapeutics Inc. (FHTX) is dated April 30, 2026. The proxy statement of Foghorn Therapeutics Inc. reports total compensation of $2,361,027 for Adrian Gottschalk in fiscal 2025, including a base salary of $638,000. Disclosed compensation is on record for 7 fiscal years. Adrian Gottschalk has spoken on 1 investor event across 1 company, most recently for Foghorn Therapeutics Inc. on June 9, 2026. Foghorn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Foghorn Therapeutics Inc. includes Jeff Sacher (CFO), Kristian F. Humer (CFO and Chief Accounting Officer), Ryan D. Maynard (CFO) and 7 others.
“Yeah, look, I think next up and most importantly as we think about 2026 is our FHD909 program. This is the selective SMARC2 inhibitor molecule that is partnered with our colleagues at Eli Lilly in a 50-50 strategic collaboration with them.”
Start not stated–present
Last confirmed April 30, 2026
Start not stated–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $638,000 | $2,361,027 |
| 2024 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $601,500 | $1,559,562 |
| 2023 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $579,000 | $2,503,942 |
| 2022 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $575,000 | $5,436,444 |
| 2021 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $540,000 | $4,315,482 |
| 2020 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $478,950 | $2,624,275 |
| 2019 | Foghorn Therapeutics Inc. (FHTX) | President and Chief Executive Officer | $465,000 | $1,305,543 |
